A low level of C3AR1 expression indicated chemotherapy resistance in colorectal and breast cancer, but increased sensitivity to chemotherapy in glioblastoma multiforme (GBM) and ovarian cancer. This evidence concerns the gene C3AR1 and breast cancer.